214 related articles for article (PubMed ID: 27035536)
21. A word to the wise about ketamine.
Schatzberg AF
Am J Psychiatry; 2014 Mar; 171(3):262-4. PubMed ID: 24585328
[No Abstract] [Full Text] [Related]
22. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.
Abdallah CG; Adams TG; Kelmendi B; Esterlis I; Sanacora G; Krystal JH
Depress Anxiety; 2016 Aug; 33(8):689-97. PubMed ID: 27062302
[TBL] [Abstract][Full Text] [Related]
23. Electroconvulsive therapy is a standard treatment; ketamine is not (yet).
Kellner CH; Greenberg RM; Ahle GM; Liebman LS
Am J Psychiatry; 2014 Jul; 171(7):796. PubMed ID: 24980176
[No Abstract] [Full Text] [Related]
24. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
Miller OH; Moran JT; Hall BJ
Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
[TBL] [Abstract][Full Text] [Related]
25. Rapid antidepressant effects of ketamine ignite drug discovery.
Dolgin E
Nat Med; 2013 Jan; 19(1):8. PubMed ID: 23295995
[No Abstract] [Full Text] [Related]
26. [Ketamine for treatment of acute depression].
Hjerrild S; Bjerre J; Pedersen RH; Videbech P
Ugeskr Laeger; 2013 Sep; 175(37):2090-3. PubMed ID: 24011203
[TBL] [Abstract][Full Text] [Related]
27. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
[TBL] [Abstract][Full Text] [Related]
28. NMDA antagonist treatment of depression.
Williams NR; Schatzberg AF
Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
[TBL] [Abstract][Full Text] [Related]
29. Targeting of NMDA receptors in the treatment of major depression.
Dang YH; Ma XC; Zhang JC; Ren Q; Wu J; Gao CG; Hashimoto K
Curr Pharm Des; 2014; 20(32):5151-9. PubMed ID: 24410564
[TBL] [Abstract][Full Text] [Related]
30. Evolving Issues in the Treatment of Depression.
Köhler-Forsberg O; Cusin C; Nierenberg AA
JAMA; 2019 Jun; 321(24):2401-2402. PubMed ID: 31125042
[No Abstract] [Full Text] [Related]
31. Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.
Lundin NB; Niciu MJ; Luckenbaugh DA; Ionescu DF; Richards EM; Vande Voort JL; Brutsche NE; Machado-Vieira R; Zarate CA
Pharmacopsychiatry; 2014 Jul; 47(4-5):141-4. PubMed ID: 24955551
[TBL] [Abstract][Full Text] [Related]
32. Sustained antidepressant response to ketamine.
Atigari OV; Healy D
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23960151
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant effects of ketamine in depressed patients.
Berman RM; Cappiello A; Anand A; Oren DA; Heninger GR; Charney DS; Krystal JH
Biol Psychiatry; 2000 Feb; 47(4):351-4. PubMed ID: 10686270
[TBL] [Abstract][Full Text] [Related]
34. Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.
Glue P; Medlicott NJ; Harland S; Neehoff S; Anderson-Fahey B; Le Nedelec M; Gray A; McNaughton N
J Psychopharmacol; 2017 Oct; 31(10):1302-1305. PubMed ID: 28441895
[TBL] [Abstract][Full Text] [Related]
35. Ketamine and the next generation of antidepressants with a rapid onset of action.
Machado-Vieira R; Salvadore G; Diazgranados N; Zarate CA
Pharmacol Ther; 2009 Aug; 123(2):143-50. PubMed ID: 19397926
[TBL] [Abstract][Full Text] [Related]
36. The role of dissociation in ketamine's antidepressant effects.
Ballard ED; Zarate CA
Nat Commun; 2020 Dec; 11(1):6431. PubMed ID: 33353946
[TBL] [Abstract][Full Text] [Related]
37. Blood D-serine levels as a predictive biomarker for the rapid antidepressant effects of the NMDA receptor antagonist ketamine.
Hashimoto K
Psychopharmacology (Berl); 2014 Oct; 231(20):4081-2. PubMed ID: 25189793
[No Abstract] [Full Text] [Related]
38. Comments on "An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder".
Hashimoto K
J Clin Psychopharmacol; 2009 Aug; 29(4):411-2; author reply 412. PubMed ID: 19593196
[No Abstract] [Full Text] [Related]
39. Ketamine's effectiveness in unipolar versus bipolar depression.
Fond G; Boyer L
Psychopharmacology (Berl); 2014 Nov; 231(22):4417-8. PubMed ID: 25315362
[No Abstract] [Full Text] [Related]
40. Investigational drugs for treating major depressive disorder.
Dhir A
Expert Opin Investig Drugs; 2017 Jan; 26(1):9-24. PubMed ID: 27960559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]